In 1937, Constant Janssen Biotech acquired an old factory building in the Statiestraat 78 in Turnhout for his growing company, which he expanded during World War II into a four-story building.
| FactSnippet No. 870,588 |
In 1937, Constant Janssen Biotech acquired an old factory building in the Statiestraat 78 in Turnhout for his growing company, which he expanded during World War II into a four-story building.
| FactSnippet No. 870,588 |
Still a student, Paul Janssen Biotech assisted in the development of paracetamol under the name Perdolan, which would later become well-known.
| FactSnippet No. 870,589 |
Paul Janssen Biotech founded his own research laboratory in 1953 on the third floor of the building in the Statiestraat, still within the Richter-Eurpharma company of his father.
| FactSnippet No. 870,590 |
Janssen Biotech was led by Paul Janssen, Bob Stouthuysen and Frans Van Den Bergh.
| FactSnippet No. 870,591 |
Janssen Biotech became the Flemish company with the largest budget for research and development.
| FactSnippet No. 870,592 |
In March 2015, Janssen Biotech licensed tipifarnib to Kura Oncology who will assume sole responsibility for developing and commercialising the anti-cancer drug.
| FactSnippet No. 870,593 |
In September 2017 it was announced that Janssen teamed up with the Biomedical Advanced Research and Development Authority, a unit of the U S Department of Health and Human Services, to create pandemic flu vaccines.
| FactSnippet No. 870,594 |
In 2021, Janssen Biotech was named as a defendant in a trial against several opioid manufacturers filed by New York Attorney General Letitia Jame.
| FactSnippet No. 870,595 |
Subsidiary Janssen Biotech, Inc was founded in Philadelphia in 1979 as Centocor Biotech, Inc, with an initial goal of developing new diagnostic assays using monoclonal antibody technology.
| FactSnippet No. 870,596 |
In June 2010, Centocor Ortho Janssen Biotech acquired RespiVert, a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases.
| FactSnippet No. 870,597 |
Janssen Biotech Pharmaceuticals was the first Western pharmaceutical company to set up a pharmaceutical factory in the People's Republic of China.
| FactSnippet No. 870,598 |
In 1976, Paul Janssen Biotech met Ma Haide was born on George Shafik Hatem, and a Lebanese-American doctor who had started working in China in 1933.
| FactSnippet No. 870,599 |
When Deng Xiaoping opened China to the West in 1978, Janssen Biotech sent Paul Appermont and Joos Horsten to set up the project.
| FactSnippet No. 870,600 |
In 1983, Janssen Biotech signed a cooperation contract to modernize production in an old chemical factory in the city of Hanzhong, in Shaanxi province.
| FactSnippet No. 870,601 |
Janssen Biotech Pharmaceuticals has developed and brought to the market about 70 new active substances, of which the most well-known are :.
| FactSnippet No. 870,602 |
Eight original Janssen Biotech drugs have been included on the WHO Model List of Essential Medicines:.
| FactSnippet No. 870,603 |